A prospective observational study of attention-deficit/hyperactivity disorder in Central and Eastern Europe and Turkey: Symptom severity and treatment options in a paediatric population

International Journal of Psychiatry in Clinical Practice

Volumn 14, Issue 2, 2010, Pages 116-126

  Ondrejka, Igor ^a   Abali, Osman ^b   Paclt, Ivo ^c   Gácser, Magdolna ^d   Iftene, Felicia ^e   Walton, Richard ^f   Harrison, Gavan ^f   Treuer, Tamá ^g   Martényi, Ferenc ^h  

^a University Hospital in Martin   (Slovakia)

^b Child and Adolescent Psychiatry   (Turkey)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^d Pandy Kalman County Hospital   (Hungary)

^e Pediatric Psychiatry Clinic   (Romania)

^f ELI LILLY AUSTRALIA PTY LTD   (Australia)

^g Eli Lilly Area Medical Center   (Austria)

^h ELI LILLY AND COMPANY   (United States)

Author keywords

Attention deficit hyperactivity disorder; Central and Eastern Europe; Diagnostic criteria; Quality of life; Treatment practices

Indexed keywords

ATOMOXETINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; RISPERIDONE;

ADOLESCENT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD PSYCHIATRY; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; COUNSELING; CZECH REPUBLIC; DISEASE SEVERITY; FAMILY THERAPY; FEMALE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCCUPATIONAL THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOEDUCATION; PSYCHOTHERAPY; RELAXATION TRAINING; ROMANIA; SLOVAKIA; SPEECH THERAPY; TURKEY (REPUBLIC);

EID: 77953213777     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651500903556511     Document Type: Article

References (38)

1. Prince JB. Pharmacotherapy of attention-deficit hyperac-tivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 2006;15:13-50.
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8.
3. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104-13.
4. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007; 161:857-64.
5. Gadow KD, Nolan EE, Litcher L, Carlson GA, Panina N, Golovakha E et al. Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren. J Am Acad Child Adolesc Psychiatry 2000; 39:1520-7.
6. Erşan EE, Doǧan O, Doǧan S, Sümer H. The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey. Eur Child Adolesc Psychiatry 2004;13:354-61.
7. Hirfanoǧlu T, Soysal AS, Gücüyener K, Cansu A, Serdaroǧlu A. A study of perceptions, attitudes, and level of knowledge among pediatricians towards attention-deficit/hyperactivity disorder. Turk J Pediatr 2008;50:160-6.
8. Gaub M, Carlson CL. Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. J Abnorm Child Psychol 1997;25:103-11.
9. Graetz BW, Sawyer MG, Hazell PL, Arney F, Baghurst P. Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry 2001;40:1410-17.
10. Erol N, Simsek Z, Oner O, Munir K. Epidemiology of attention problems among Turkish children and adolescents: a national study. J Atten Disord 2008;11:538-45.
11. Mann EM, Ikeda Y, Mueller CW, Takahashi A, Tao KT, Humris E, et al. Cross-cultural differences in rating hyperactive-disruptive behaviors in children. Am J Psychiatry 1992;149:1539-42.
12. Stevens SE, Sonuga-Barke EJ, Kreppner JM, Beckett C, Castle J, Colvert E, et al. Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence. J Abnorm Child Psychol 2008; 36:385-98. (Pubitemid 351421871)
13. Lahey BB, Pelham WE, Chronis A, Massetti G, Kipp H, Ehrhardt A, et al. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. J Child Psychol Psychiatry 2006;47:472-9.
14. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-33.
15. Voeller KK. Attention-deficit hyperactivity disorder (ADHD). J Child Neurol 2004;19:798-814.
16. Nolan EE, Gadow KD, Sprafkin J. Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren. J Am Acad Child Adolesc Psychiatry 2001;40:241-9.
17. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. J Am Med Assoc 1998; 279:1100-7.
18. Hechtman L. Assessment and diagnosis of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:481-98.
19. Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching D P. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord 2004; 7:163-73.
20. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Paediatrics 2004;114: e541-7.
21. Aras S, Varol TF, Unlu G. Medication prescribing practices in a child and adolescent psychiatry outpatient clinic. Child Care Health Dev 2007;33:482-90.
22. Ercan ES, Varan A, Deniz U. Effects of combined treatment on Turkish children diagnosed with attention-deficit/hyperactivity disorder: a preliminary report. J Child Adolesc Psychopharmacol 2005;15:203-19.
23. MartÉnyi F, Treuer T, Gau SF, Hong SD, Palackzy M, et al. Attention-Deficit/Hyperactivity Disorder: diagnosis, comor-bidities, treatment patterns and quality of life in a paediatric population in Central and Eastern Europe and Asia. J Child Adolesc Psychopharmacol 2008. J Child Adolesc Psychopharmacol 2009;19:363-76.
24. Gadow KD, Sprafkin J. Childhood Symptom Inventory-4 Norms/Manual. Stony Brook, NY: Checkmate Plus; 2002.
25. Guy W. ECDEU assessment manual for psychopharmacology. Bethesda, MD: US Department of Health, Education and Welfare; revised 1976.
26. Gadow KD, Sprafkin J. Adolescent symptom inventory 4, screening manual. Stony Brook, NY: Checkmate Plus; 1997.
27. Riley AW, Robertson J, Forrest CB, Green B, Rebok G, Starfield B. Manual for the child health and illness profile - child edition (CHIP-CE). Baltimore, MD: The Johns Hopkins University; 2001.
28. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159:36-42.
29. Quinn P, Wigal S. Perceptions of girls and ADHD: results from a national survey. MedGenMed 2004;6:2.
30. Pliszka SR. Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychol Rev 2007;17:61-72.
31. Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/ hyperactivity disorder (ADHD). Curr Med Res Opin 2007; 23:379-94.
32. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Paediatrics 2008;121:e314-20.
33. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guildford Press; 1998.
34. Elia J, Ambrosini P, Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents. Child Adolesc Psychiatry Ment Health 2008;2:15.
35. The MTA Cooperative Group. A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86.
36. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-77.
37. Ralston SJ, Lorenzo MJ. ADORE - Attention-deficit hyper-activity disorder observational research in Europe. Eur Child Adolesc Psychiatry 2004;13 (Suppl. 1):I36-42.
38. Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I. Worse quality of life for children with newly diagnosed attention-deficit/ hyperactivity disorder, compared with asthmatic and healthy children. Paediatrics 2005; 116:e364-9.